Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Astrazeneca Plc Ord (OP: AZNCF ) 153.41 -0.45 (-0.29%) Streaming Delayed Price Updated: 3:27 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Astrazeneca Plc Ord < Previous 1 2 3 4 5 6 7 8 Next > Daiichi Sankyo - AstraZeneca's Enhertu Receives Priority Review In US For Lung Cancer April 19, 2022 Via Benzinga After Encouraging Data, Blueprint Medicines Plans Combination Cohort In Tagrisso Resistant Lung Cancer April 11, 2022 Blueprint Medicines Corp (NASDAQ: BPMC) Via Benzinga Seagen Wins $42M Patent Claim Against Daiichi In Cancer Drug Case April 11, 2022 A jury in Marshall, Texas, awarded Seagen Inc (NASDAQ: SGEN) Via Benzinga AstraZeneca Bets $25M On Preclinical Bispecific Antibody April 07, 2022 Via Benzinga FDA Official Says Frequent COVID-19 Booster Shows Not Sustainable: WSJ April 07, 2022 According to a U.S. health regulator, asking people to get COVID-19 boosters frequently wasn't sustainable because of vaccine fatigue, and authorities needed to develop a long-term strategy for... Via Benzinga AstraZeneca's Imfinzi Flunks In Late-Stage Advanced Cervical Cancer Study March 24, 2022 Via Benzinga AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease April 06, 2022 Via Benzinga Ionis Pharma - AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol April 04, 2022 Ionis Pharmaceuticals Inc (NASDAQ: IONS) and its partner, AstraZeneca Plc (NASDAQ: AZN), have Via Benzinga EMA Recommends Approval Of AstraZeneca's COVID-19 Therapy, Evusheld March 24, 2022 EMA's human medicines committee (CHMP) has Via Benzinga AstraZeneca's COVID-19 Vaccine Expected To Win European Approval This Week: Reuters March 23, 2022 European Medicines Agency is expected to approve AstraZeneca Plc's (NASDAQ: AZN) antibody-based COVID-19 vaccine for preventing COVID-19 infections, Via Benzinga Bristol Myers Sues AstraZeneca Over PD-L1 Cancer Drug Patents March 21, 2022 Bristol Myers Squibb Co (NYSE: BMY) claims that AstraZeneca Plc's (NASDAQ: AZN) PD-L1 inhibitor, Imfinzi, infringed on at least eight patents in a newly filed complaint. Via Benzinga AstraZeneca's COVID-19 Antibody Neutralizes Omicron Sub-variants, Lab Study Shows March 21, 2022 AstraZeneca Plc's (NASDAQ: AZN) antibody-based cocktail to prevent and treat COVID-19 retained Via Benzinga AstraZeneca Mulls Ditching US Approval For Its COVID-19 Vaccine: FT March 18, 2022 Citing AstraZeneca Plc's (NASDAQ: AZN) head of research and development, the Financial Times reported that the Company Via Benzinga AstraZeneca Settles Ultomiris-Related Patent Litigation With Chugai March 17, 2022 Alexion Pharmaceuticals, a unit of AstraZeneca plc (NASDAQ: AZN), has entered into a settlement agreement with Chugai Pharmaceutical Co Ltd, resolving all patent disputes related to Ultomiris... Via Benzinga AstraZeneca's COVID-19 Therapy Approved In Britain As Preventive Option March 17, 2022 Britain's Medicines and Healthcare products Regulatory Agency (MHRA) Via Benzinga Europe Kickstarts Reviewing AstraZeneca Application For Its COVID Antibody March 16, 2022 Via Benzinga White House Warns It Cannot Afford COVID-19 Related Solutions If Cases Increase: FT March 16, 2022 The White House says that the U.S. is running out of money to pay for COVID-19 vaccines, tests, and treatments, making it unprepared for any rising cases in the future. Via Benzinga Merck-AstraZeneca Stop Keytruda/Lynparza Combo Trial In Prostate Cancer Patients March 15, 2022 Merck & Co Inc (NYSE: MRK) will stop the Phase 3 KEYLYNK-010 trial investigating Keytruda combined with Lynparza for metastatic castration-resistant prostate cancer (mCRPC). Via Benzinga FDA Declines To Approve AstraZeneca's Asthma Treatment For Chronic Nasal Condition March 14, 2022 The FDA has declined to approve AstraZeneca Plc's (NASDAQ: AZN) asthma medicine, Fasenra (benralizumab), to treat chronic rhinosinusitis with nasal polyps, a... Via Benzinga AstraZeneca-Merck's Lynparza Wins FDA Approval For Early-Stage Breast Cancer March 14, 2022 The FDA has approved AstraZeneca Plc's (NASDAQ: AZN) cancer drug, jointly developed with Merck & Co Inc (NYSE: MRK) to treat patients with early-... Via Benzinga AstraZeneca-Sanofi's Nirsevimab Shows 75% Efficacy Against RSV In Healthy Infants March 03, 2022 AstraZeneca Plc (NASDAQ: AZN) and Sanofi SA (NASDAQ: SNY) have shared detailed results from the MELODY Phase 3 trial evaluating nirsevimab in respiratory... Via Benzinga AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants February 25, 2022 The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab).... Via Benzinga Blood Clot Risk After First AstraZeneca COVID-19 Shot Very Small - UK Study Shows February 23, 2022 A large study into rare blood clots linked with AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine found between one and three cases per million, and only after... Via Benzinga Roche And AstraZeneca Settle Ultomiris Patent Lawsuit February 22, 2022 Roche Holdings AG (OTC: RHHBY) has decided to close out a patent infringement lawsuit against AstraZeneca plc (NASDAQ: AZN), centering around the latter's newly... Via Benzinga AstraZeneca's Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting February 22, 2022 AstraZeneca plc (NASDAQ: AZN) said that Enhertu prolonged survival and slowed the progression of metastatic breast cancer with low levels of a protein known as HER2... Via Benzinga GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women February 18, 2022 GlaxoSmithKline plc (NYSE: GSK) has paused a late-stage trial of its respiratory syncytial virus (RSV) vaccine candidate in pregnant women based on safety... Via Benzinga Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters February 16, 2022 According to officials and internal World Health Organization documents reviewed by Reuters, the relatively short shelf life of AstraZeneca Plc's (NASDAQ: AZN)... Via Benzinga Why Are AstraZeneca Shares Trading Higher Today February 15, 2022 Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease... Via Benzinga AstraZeneca Records Bumper COVID-19 Vaccine Sales Of ~$4B In FY21 February 10, 2022 AstraZeneca Plc's (NASDAQ: AZN) total revenue jumped 63% Y/Y to $12.0 Via Benzinga AstraZeneca Dumps Off Mid-Stage Cardiovascular Drug To Regio Biosciences February 03, 2022 AstraZeneca plc (NASDAQ: AZN) has granted Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.